Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.

Vol.22 No.4

Letter

Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.

Authors

Isamu Yokoe¹ , Shinya Nishio¹ , Hiroshi Sato¹ , Hitomi Kobayashi¹

Division of Rheumatology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashi-ku, Tokyo, 1740051, Japan

Received:

30 November 2011

Accepted:

11 May 2012

Published online:

14 June 2012

Full Text

PDF　(member's only)

Abstract

Without Abstract

Key words

Matrix metalloproteinase-3 (MMP-3) - Prednisolone